Cardiac resynchronization therapy with or without defibrillation in patients with nonischemic cardiomyopathy: a systematic review and meta-analysis

D Patel, A Kumar, E Black-Maier… - Circulation …, 2021 - Am Heart Assoc
Background: Cardiac resynchronization therapy (CRT) represents a major medical advance
in patients with heart failure with electrical dyssynchrony to improve symptoms, reduce …

An updated meta-analysis of cardiac resynchronization therapy with or without defibrillation in patients with nonischemic cardiomyopathy

F Liu, X Gao, J Luo - Frontiers in Cardiovascular Medicine, 2023 - frontiersin.org
Background Cardiac resynchronization therapy (CRT) is a major device therapy used to
treat patients suffering from heart failure (HF) and electrical asynchrony. It can improve HF …

Long-term clinical outcomes of cardiac resynchronization therapy with or without defibrillation: impact of the aetiology of cardiomyopathy

F Leyva, A Zegard, F Umar, RJ Taylor, E Acquaye… - EP …, 2018 - academic.oup.com
Aims There is a continuing debate as to whether cardiac resynchronization therapy-
defibrillation (CRT-D) is superior to CRT-pacing (CRT-P), particularly in patients with non …

Outcomes of cardiac resynchronization therapy with or without defibrillation in patients with nonischemic cardiomyopathy

F Leyva, A Zegard, E Acquaye, C Gubran… - Journal of the American …, 2017 - jacc.org
Background: Recent studies have cast doubt on the benefit of cardiac resynchronization
therapy (CRT) with defibrillation (CRT-D) versus pacing (CRT-P) for patients with …

Is CRT-D superior to CRT-P in patients with nonischemic cardiomyopathy?

M Al-Sadawi, F Aslam, M Tao, S Salam… - International Journal of …, 2023 - Springer
Background Recent studies have questioned the role of implanted cardiac defibrillators
(ICDs) in nonischemic cardiomyopathy (NICM). Cardiac resynchronization therapy (CRT) …

The benefits of defibrillator in heart failure patients with cardiac resynchronization therapy: A meta‐analysis

YX Long, Y Hu, DY Cui, S Hu… - Pacing and Clinical …, 2021 - Wiley Online Library
Background Current guidelines did not provide recommendations on indications of an
additional implantable cardioverter‐defibrillator (ICD) to patients receiving cardiac …

Efficacy of implantable cardioverter-defibrillator therapy in patients with nonischemic cardiomyopathy: a systematic review and meta-analysis of randomized controlled …

M Anantha Narayanan, K Vakil, YN Reddy… - JACC: Clinical …, 2017 - jacc.org
Objectives: This study sought to evaluate the efficacy of implantable cardioverter-defibrillator
(ICD) therapy with or without cardiac resynchronization therapy (CRT) in patients with …

Cardiac resynchronization therapy using pacemakers vs defibrillators in patients with nonischemic cardiomyopathy: the United States experience from 2007 to 2014

S Saba, T McLaughlin, M He, A Althouse, S Mulukutla… - Heart Rhythm, 2019 - Elsevier
Background The impact of implantable defibrillator therapy on outcomes of patients with
nonischemic cardiomyopathy (NICM) who receive a cardiac resynchronization therapy …

The addition of a defibrillator to resynchronization therapy decreases mortality in patients with nonischemic cardiomyopathy

B Doran, C Mei, PD Varosy, DP Kao, LA Saxon… - Heart Failure, 2021 - jacc.org
Objectives The aim of this study was to determine whether patients with heart failure with
reduced ejection fraction (HFrEF) due to nonischemic etiology eligible for cardiac …

Impact of etiology on the outcomes in heart failure patients treated with cardiac resynchronization therapy: a meta-analysis

Y Chen, C Duan, F Liu, S Shen, P Chen, J Bin - PLoS One, 2014 - journals.plos.org
Background Cardiac resynchronization therapy (CRT) has been extensively demonstrated
to benefit heart failure patients, but the role of underlying heart failure etiology in the …